Skip to product information
Understanding the Pharmaceutical and Biotechnology Industry in Just One Day
Understanding the Pharmaceutical and Biotechnology Industry in Just One Day
Description
Book Introduction
“A book that explains the big picture and core concepts of the pharmaceutical and bio industries in a truly easy-to-understand way!”

Many people diligently study the pharmaceutical and biotechnology industries, researching related news, analyst reports, and specialized books to understand them.
But soon you become overwhelmed by the sheer number of terms: GLP-1, mRNA, ligand, ADC, biosimilar, CDMO, Keytruda, PD-1, CAR-T, immune checkpoint, EGFR, milestone, ORR, etc.
Even separating technical terms from the names of pharmaceutical products is a challenge.


How on earth should I study pharmaceuticals and biotechnology?

You have to understand the big picture first.
You can't get the answer by looking at the trees without knowing the forest.
It's like having a world map makes it easy to understand the relationships and structures of each country, but without a world map, no matter how much you study each country, you can't grasp the overall concept.
"Understanding the Pharmaceutical and Bio Industries in Just One Day" was born with this planning intention.
We've made it as easy as possible to understand the industry's big picture and core concepts, using a variety of examples and abundant illustrations to help even non-experts understand it.
I hope this book will faithfully fulfill its role as a compass for policymakers, a microscope for businesspeople and investors to examine opportunities and risks, and a navigation system for job seekers exploring their career paths.
  • You can preview some of the book's contents.
    Preview

index
Recommendation
prolog

PART 01 Basic knowledge for understanding industry

1.
Cells, the basic unit of life
Cell division and differentiation
signaling molecules
2.
The internal structure of cells and the roles of cell organelles
cell organelles
DNA and RNA
▶Just the essentials!
▶One step further!

PART 02 How Cancer and Anticancer Drugs Work

1.
What is cancer?
Definition of cancer
Market size and status
cancer treatment
2.
Generational classification of anticancer drugs
first-generation anticancer drugs
second-generation anticancer drugs
3rd generation anticancer drugs
3.
immune system
innate immune cells
acquired immune cells
4.
How anticancer drugs work
Antibody drugs and antibody drug conjugates
tyrosine kinase inhibitors
immune checkpoint inhibitors (inhibitors)
cell therapy
5.
Types and administration methods (formulations) of anticancer drugs
Types of anticancer drugs
Method of administration (formulation)
▶Just the essentials!
▶One step further!

PART 03 Blockbuster New Drugs and Leading Companies by Cancer Type

1.
lung cancer
Basic information
Anticancer drugs and representative companies
2.
breast cancer
Basic information
Anticancer drugs and representative companies
3.
melanoma
Basic information
Anticancer drugs and representative companies
4.
leukemia
Basic information
Anticancer drugs and representative companies
5.
colon cancer
Basic information
Anticancer drugs and representative companies
6.
prostate cancer
Basic information
Anticancer drugs and representative companies
7.
Cancers for which there are no effective anticancer drugs
liver cancer
pancreatic cancer
▶Just the essentials!
▶One step further!

PART 04 Autoimmune Diseases & Vaccines

1.
autoimmune diseases
Understanding Autoimmune Diseases
Market size and status
Treatments and representative companies
2.
vaccine
The Birth of a Vaccine
Types of vaccines
Understanding Vaccines Through COVID-19
cancer vaccine
Market size and representative companies
▶Just the essentials!
▶One step further!

PART 05 Diabetes & Obesity

1.
diabetes
Understanding Diabetes
Insulin secretion mechanism
Beyond diabetes treatment to obesity treatment
2.
obesity
Understanding Obesity
Expansion of representative companies and indications
▶Just the essentials!
▶One step further!

PART 06 Synthetic Drugs and Biopharmaceuticals

1.
Classification of drugs
Pharmaceuticals and Bio
Classification of drugs
2.
Synthetic drugs and biopharmaceuticals
Characteristics of synthetic drugs and biopharmaceuticals
Market size
Representative companies
▶Just the essentials!
▶One step further!

PART 07 New Drug Development Process, Production, and Sales (+Health Insurance)

1.
New drug development process
Candidate substance exploration
Nonclinical (preclinical) trials
clinical trials
2.
Two ways to shorten development time
FDA's expedited review program
sophisticated clinical protocols
3.
Production of new drugs
demanding production conditions
4.
Sales of new drugs
Different insurance systems in each country
Korean health insurance
▶Just the essentials!
▶One step further!

PART 08 Industrial Division of Labor and National Competitiveness

1.
Division of labor system between discovery and development stages
Technology transfer (export)
Clinical trial contract organization
Provision of experimental tools and consumables
Provision of experimental animals
Consignment development
2.
Division of labor system at the production stage
contract manufacturing
Quality control and distribution of pharmaceuticals
3.
Competitiveness by country
USA
europe
korea
Japan and China
▶Just the essentials!
▶One step further!

PART 09 Diagnosis and AI Medicine

1.
Understanding the Diagnostic Market
In vitro diagnosis
Leading in vitro diagnostics company
In-vivo diagnosis
Leading in-vivo diagnostic company
2. Understanding AI Medicine
AI meets pharmaceuticals and biotechnology
AI drug development
Representative companies
▶Just the essentials!
▶One step further!

PART 10: The Essentials of Pharmaceutical and Biotech Investment

1.
What is an academic society?
Academic momentum
Important conferences you must attend
2.
Three Trends in M&A and Technology Transfer
radioactive pharmaceuticals
CMO/CDMO
ADC
3.
Summary of domestic companies' clinical trials by stage
Commercialization stage
Phase 3 clinical trial
Phase 2 clinical trial
Phase 1 clinical trial
▶Just the essentials!
▶One step further!

Epilogue
See image

Detailed image
Detailed Image 1

Publisher's Review
Former Analyst Kang Ha-na Explains the Essentials of Pharmaceutical and Bio Investment

We've explained the big picture and core concepts of the pharmaceutical and biotechnology industries in the simplest possible way, using a variety of examples and abundant illustrations.
After reading this book, you'll understand everything covered in pharmaceutical and biotechnology news and analyst reports.
I highly recommend this book to investors, job seekers, and industry professionals interested in pharmaceutical and biotechnology companies.
GOODS SPECIFICS
- Date of issue: October 31, 2024
- Page count, weight, size: 360 pages | 170*234*21mm
- ISBN13: 9791191590289
- ISBN10: 1191590283

You may also like

카테고리